Table 1.
Parameters | Survivors (n = 153) | Nonsurvivors (n = 147) | P value |
---|---|---|---|
Age (years) | 61.8 ± 15.6 | 64.1 ± 15.2 | 0.200 |
Gender, n (%) | — | — | 0.089 |
Male | 94 (61.4%) | 104 (70.7%) | — |
Female | 59 (38.6%) | 43 (29.3%) | — |
Comorbidities | — | — | — |
Hypertension, n (%) | 28 (18.3%) | 38 (25.9%) | 0.115 |
Diabetes mellitus, n (%) | 22 (14.4%) | 30 (20.4%) | 0.168 |
Chronic lung disease, n (%) | 3 (2.0%) | 10 (6.8%) | 0.038∗ |
Cardiac disease, n (%) | 12 (7.8%) | 16 (10.9%) | 0.365 |
Chronic renal disease, n (%) | 9 (5.9%) | 17 (11.6%) | 0.080 |
Body temperature (°C) | 37.1 ± 1.0 | 37.3 ± 1.2 | 0.124 |
Heart rate (per minute) | 105.8 ± 24.5 | 116.0 ± 26.6 | <0.001∗ |
Respiratory rate (per minute) | 21.2 ± 6.0 | 24.7 ± 7.3 | <0.001∗ |
Mean atrial pressure (mmHg) | 79.4 ± 18.1 | 75.4 ± 20.9 | 0.007∗ |
Mechanical ventilation, n (%) | 82 (53.6%) | 105 (71.4%) | 0.001∗ |
Continuous renal replacement therapy, n (%) | 29 (19.0%) | 41 (27.9%) | 0.067 |
Septic shock, n (%) | 111 (72.5%) | 145 (98.6%) | <0.001∗ |
APACHE II score | 15.9 ± 5.1 | 25.5 ± 7.7 | <0.001∗ |
SOFA score | 8.2 ± 4.0 | 12.3 ± 4.0 | <0.001∗ |
GCS score | 15.0 (P25 12.0-P7515.0) | 7.0 (P25 3.0-P7514.0) | <0.001∗ |
Site of infection | — | — | 0.004∗ |
Respiratory system, n (%) | 32 (20.9%) | 42 (28.6%) | — |
Genitourinary system, n (%) | 10 (6.5%) | 12 (8.2%) | — |
Gastrointestinal system, n (%) | 30 (19.6%) | 27 (18.3%) | — |
Bloodstream, n (%) | 22 (14.5%) | 34 (23.1%) | — |
Hepatobiliary system, n (%) | 0 (0.0%) | 2 (1.4%) | — |
Central nervous system, n (%) | 0 (0.0%) | 2 (1.4%) | — |
Unknown, n (%) | 59 (38.5%) | 28 (19%) | — |
APACHE II: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; GCS: Glasgow Coma Scale; P values were calculated by chi-square test, Fisher's exact test, Student's t-test, or Mann–Whitney U test; ∗P < 0.05 indicates statistical significance.